ClinicalTrials.Veeva

Menu

Improving Outcomes After AF Ablation in Obese Patients (OBESE-AF)

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

Atrial Fibrillation (AF)
Obesity (Disorder)

Treatments

Behavioral: Usual Care
Behavioral: Cardiac Rehabilitation and Lifestyle Modification

Study type

Interventional

Funder types

Other

Identifiers

NCT07618741
202006062RINC

Details and patient eligibility

About

Improving Outcomes After AF Ablation in Obese Patients

Full description

This is a prospective randomized clinical study designed to evaluate the roles of gut microbiota dysbiosis, adipose tissue biology, and post-ablation lifestyle intervention in patients with atrial fibrillation undergoing catheter ablation. Patients with paroxysmal or persistent atrial fibrillation who are scheduled to undergo catheter ablation at National Taiwan University Hospital will be enrolled after informed consent.

All participants will undergo standard-of-care catheter ablation and receive guideline-directed management for atrial fibrillation, including treatment of cardiovascular conditions, anticoagulation, and rate or rhythm control as clinically indicated. After the index ablation procedure, participants will be randomly assigned in a 1:1 ratio to either an intensive lifestyle modification program or usual care.

Participants assigned to the intensive lifestyle modification group will receive dietary counseling for weight reduction when indicated and an exercise-based cardiac rehabilitation program. The rehabilitation program will include supervised aerobic exercise and resistance or strength training, together with recommendations for home-based moderate-intensity walking exercise. Participants assigned to the usual care group will continue their usual lifestyle and receive standard post-ablation clinical follow-up.

The study will collect clinical characteristics, procedural data, rhythm follow-up data, biological samples, and imaging-based measurements. Gut microbiota dysbiosis will be assessed using stool specimens and high-throughput sequencing of the V3 and V4 hypervariable regions of 16S rRNA. Adipose tissue biology will be evaluated using computed tomography to quantify the amount and distribution of adipose tissue, including epicardial, paracardial, pericardial, visceral, and subcutaneous fat. Serum biomarkers related to inflammation and fibrosis, including hs-CRP, TNF-alpha, IL-1 beta, ST2, and galectin-3, will also be assessed.

Cardiac structural remodeling will be evaluated using cardiac computed tomography and echocardiography, including left atrial size, left ventricular mass, left ventricular ejection fraction, and parameters of left ventricular diastolic function. Electrophysiological remodeling of the left atrium will be assessed using three-dimensional voltage mapping during the ablation procedure, including the extent of scar and low-voltage zones.

Participants will undergo rhythm follow-up after catheter ablation using 12-lead electrocardiography, continuous patch electrocardiographic monitoring, and Holter monitoring as clinically indicated. The study will evaluate AF-free survival after the blanking period and will explore whether the post-ablation lifestyle intervention modifies ablation outcomes, body mass index, metabolic parameters, gut microbiota dysbiosis, adipose tissue biology, cardiac structural remodeling, and electrophysiological remodeling.

Enrollment

520 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University Hospital.

Exclusion criteria

  1. Informed consent could not be obtained due to personal problem
  2. Unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular
  3. Current or scheduled enrollment in other conflicting studies, and
  4. Concomitant disease or other medical condition likely to result in death within 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

520 participants in 2 patient groups

Cardiac rehabilitation
Experimental group
Description:
Participants assigned to this arm will receive an intensive lifestyle modification program after the index catheter ablation procedure. The program includes an exercise-based cardiac rehabilitation program with aerobic exercise and resistance or strength training, in addition to standard post-ablation care.
Treatment:
Behavioral: Cardiac Rehabilitation and Lifestyle Modification
Usual Care
Active Comparator group
Description:
Participants assigned to this arm will continue their usual lifestyle and receive standard post-ablation clinical follow-up after the index catheter ablation procedure.
Treatment:
Behavioral: Usual Care

Trial contacts and locations

1

Loading...

Central trial contact

Chun Kai, Chen Visiting staff, MD; Yen Bin, Liu Associate Professor of Medicine, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems